Genesis Private Wealth’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$396K Buy
5,067
+677
+15% +$54.6K 0.11% 104
2026
Q1
$380K Buy
4,390
+1,657
+61% +$159K 0.12% 103
2025
Q4
$263K Buy
2,733
+17
+0.6% +$1.65K 0.08% 141
2025
Q3
$259K Sell
2,716
-560
-17% -$51.5K 0.11% 120
2025
Q2
$286K Buy
3,276
+651
+25% +$55.2K 0.13% 96
2025
Q1
$236K Buy
+2,625
New +$235K 0.13% 115

Other funds holding MDT

Genesis Private Wealth's MDT Position: Q2 2026 in Review

Genesis Private Wealth increased its Medtronic (MDT) stake by 15% in Q2 2026, buying an estimated $54.6K and bringing the position to 5,067 shares worth $396K. The position accounts for 0.11% of the portfolio, ranked #104.

Genesis Private Wealth first reported a position in MDT in Q1 2025 and has held it in 6 quarters since. 486 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Genesis Private Wealth held 5,067 shares of Medtronic worth $396K as of Q2 2026.
  • Genesis Private Wealth bought 677 Medtronic shares in Q2 2026, an estimated $54.6K.
  • Medtronic made up 0.11% of Genesis Private Wealth's portfolio in Q2 2026, its #104 holding.
  • Genesis Private Wealth first reported a position in Medtronic in Q1 2025 and has held it in 6 quarters since.
  • 486 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Genesis Private Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.